AU7221798A - Use of a modified baculovirus containing exogenous nucleic acid for the manufacture of a medicament for delivering said nucleic acid to the hepatocytes - Google Patents

Use of a modified baculovirus containing exogenous nucleic acid for the manufacture of a medicament for delivering said nucleic acid to the hepatocytes

Info

Publication number: AU7221798A
Authority: AU; Australia
Prior art keywords: nucleic acid; hepatocytes; medicament; delivering; manufacture
Prior art date: 1997-04-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU72217/98A

Inventor

Michael Joseph Mcgarvey

Howard Christopher Thomas

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ip2ipo Innovations Ltd

Original Assignee

Imperial College Innovations Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-29

Filing date

1998-04-29

Publication date

1998-11-24

1998-04-29 Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd

1998-11-24 Publication of AU7221798A publication Critical patent/AU7221798A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Virology (AREA)
Physics & Mathematics (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Public Health (AREA)
Plant Pathology (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU72217/98A 1997-04-29 1998-04-29 Use of a modified baculovirus containing exogenous nucleic acid for the manufacture of a medicament for delivering said nucleic acid to the hepatocytes Abandoned AU7221798A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9708698		1997-04-29
GBGB9708698.7A GB9708698D0 (en)	1997-04-29	1997-04-29	Materials for therapy
PCT/GB1998/001249 WO1998048842A1 (en)	1997-04-29	1998-04-29	Use of a modified baculovirus containing exogenous nucleic acid for the manufacture of a medicament for delivering said nucleic acid to the hepatocytes

Publications (1)

Publication Number	Publication Date
AU7221798A true AU7221798A (en)	1998-11-24

Family

ID=10811549

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU72217/98A Abandoned AU7221798A (en)	1997-04-29	1998-04-29	Use of a modified baculovirus containing exogenous nucleic acid for the manufacture of a medicament for delivering said nucleic acid to the hepatocytes

Country Status (4)

Country	Link
EP (1)	EP0979106A1 (en)
AU (1)	AU7221798A (en)
GB (1)	GB9708698D0 (en)
WO (1)	WO1998048842A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6183993B1 (en) *	1996-09-11	2001-02-06	The General Hospital Corporation	Complement-resistant non-mammalian DNA viruses and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH10506530A (en) *	1994-09-23	1998-06-30	ザジェネラルホスピタルコーポレーション	Use of a non-mammalian DNA virus expressing foreign genes in mammalian cells
BR9712978A (en) *	1996-09-11	2000-04-18	Gen Hospital Corp	Non-mammalian DNA viruses having an altered coating protein

1997
- 1997-04-29 GB GBGB9708698.7A patent/GB9708698D0/en active Pending
1998
- 1998-04-29 EP EP98919340A patent/EP0979106A1/en not_active Withdrawn
- 1998-04-29 AU AU72217/98A patent/AU7221798A/en not_active Abandoned
- 1998-04-29 WO PCT/GB1998/001249 patent/WO1998048842A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO1998048842A1 (en)	1998-11-05
EP0979106A1 (en)	2000-02-16
GB9708698D0 (en)	1997-06-18

Similar Documents

Publication	Publication Date	Title
AU8525098A (en)	1999-02-16	Liposomal compositions for the delivery of nucleic acid catalysts
AU613039B2 (en)	1991-07-25	Dispenser with dispersing member for delivering beneficial agent
AU3569800A (en)	2000-10-23	Pyrimidine compounds with pharmaceutical activity
KR20010012511A (en)	2001-02-15	A new process for the preparation of a pharmacologically active substance
EP1001813B8 (en)	2014-02-12	Pharmaceutical formulations containing voriconazole
AU5743996A (en)	1996-10-30	Compositions and methods for nucleic acid delivery to the lu ng
AU7375598A (en)	1998-11-27	Stable oral pharmaceutical dosage forms
CZ8193A3 (en)	1994-01-19	Pharmaceutical dosing form with prolonged release of active compound
SI0979269T1 (en)	2003-02-28	Use of a fermenter
AU1943899A (en)	1999-07-12	Methods for delivering pharmaceutical agents to mucosal surfaces
AU1061699A (en)	1999-04-23	Use of biologically active glass as a drug delivery system
AU7032500A (en)	2001-04-24	A process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
IL154114A0 (en)	2003-07-31	Composition for use as a medicament for increasing levels of endogeneous growth hormone
AU5428700A (en)	2001-01-31	Acrylic acid derivatives, use of the same and intermediates for the preparation thereof
GB9706381D0 (en)	1997-05-14	Improvements relating to the specificity of gene expression
AU6935498A (en)	1998-10-30	Novel phosphate compounds and their use as medicaments
HU9701080D0 (en)	1997-08-28	Pharmaceutical composition of antiviral activity
IL106743A0 (en)	1993-12-08	Tablets with improved bioavailability of the active material clodronic acid
AU2001240674A1 (en)	2001-09-24	Dihydropyrimidine-5-carboxylic acid esters and use thereof as medicaments against viral diseases
IL123849A0 (en)	1998-10-30	Pharmaceutical composition useful for nucleic acid transfection and use thereof
AU5534794A (en)	1994-05-24	Plaster with a supply of a medically active substance
HU9802716D0 (en)	1999-01-28	Pharmaceutical composition of analgesic activity
AU7221798A (en)	1998-11-24	Use of a modified baculovirus containing exogenous nucleic acid for the manufacture of a medicament for delivering said nucleic acid to the hepatocytes
IL148907A0 (en)	2002-09-12	Preparation containing active ingredients and/or auxiliary agents with a controlled release of these substances and the use and production of the same
AU4417000A (en)	2000-11-02	Novel pharmaceutical composition suitable for gene therapy

Legal Events

Date	Code	Title	Description
2000-02-03	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase